178 related articles for article (PubMed ID: 20345216)
1. Posttreatment prognosis of patients with esthesioneuroblastoma.
Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Buencamino R; Fang S; Barani IJ; Parsa AT
J Neurosurg; 2010 Aug; 113(2):340-51. PubMed ID: 20345216
[TBL] [Abstract][Full Text] [Related]
2. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
3. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
5. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
6. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
[TBL] [Abstract][Full Text] [Related]
10. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
12. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
[TBL] [Abstract][Full Text] [Related]
13. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
McElroy EA; Buckner JC; Lewis JE
Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546
[TBL] [Abstract][Full Text] [Related]
15. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
16. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.
Miller KC; Marinelli JP; Van Gompel JJ; Link MJ; Janus JR; Foote RL; Price KA; Garcia J; Rivera M; Chintakuntlawar AV
Head Neck; 2019 May; 41(5):1335-1341. PubMed ID: 30536472
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 20 adults esthesioneuroblastoma with combined therapy].
Li JS; Xie FY; Peng M; Han F
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):36-9. PubMed ID: 19484986
[TBL] [Abstract][Full Text] [Related]
18. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.
Jethanamest D; Morris LG; Sikora AG; Kutler DI
Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
[TBL] [Abstract][Full Text] [Related]
20. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]